HEAL R03: Early-stage discovery of pain targets in understudied druggable proteome (no clinical trials)
This NIH HEAL R03 NOFO funds one-year, non-renewable small grants to generate preliminary data and research tools that elucidate the function of listed understudied druggable proteins in pain and pain management. Applications must be non-clinical (clinical trials not allowed), justify why chosen protein(s) are relevant to pain, and aim to enable follow-on grants or drug-discovery efforts while…
This study is part of the Helping to End Addiction Long-term ® Initiative, or NIH HEAL Initiative ® , to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to (1) improve treatment for opioid misuse and addiction and (2) e…
Funding Source
Awards & funding
Eligibility
Applicant organizations must be domestic (U.S.) entities. Non-domestic (non-U.S.) entities/foreign organizations are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply as applicants. Foreign components, as defined in the NIH Grants Policy St…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers